Edinburgh, United Kingdom

Arun Gupta

This inventor holds 1 USPTO granted patent. Top assignee: The University of Edinburgh. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arun Gupta. Retrieved from https://idiyas.com/inventor/arun-gupta-1jo3a5z3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arun Gupta: Innovator in Cyclophilin Modulation

Introduction

Arun Gupta is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of cyclophilins. His work focuses on developing compounds that can serve as inhibitors of cyclophilins and modulators of cyclophilin-like proteins.

Latest Patents

Arun Gupta holds a patent for "Compounds for the modulation of cyclophilins function." This invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, which are useful in treating various disorders. The patent outlines the structural components of these compounds, detailing the various groups and substituents that can be included to enhance their efficacy.

Career Highlights

Arun Gupta is affiliated with The University of Edinburgh, where he conducts research and develops innovative solutions in the pharmaceutical domain. His work has led to advancements in understanding how cyclophilins function and how they can be targeted for therapeutic purposes.

Collaborations

He has collaborated with esteemed colleagues such as Alessio De Simone and Malcolm Walkinshaw, contributing to a rich environment of research and innovation.

Conclusion

Arun Gupta's contributions to the field of cyclophilin modulation exemplify the impact of innovative research in pharmaceuticals. His patent and ongoing work at The University of Edinburgh highlight the importance of scientific inquiry in developing new treatments for various disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…